Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib plus aromatase inhibitor in metastatic breast cancer
NCT01484041Phase 2Terminated
- Sponsor
- Georgetown University
- Start
- Apr 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovitinib in breast cancer, sponsored by Georgetown University. Started Apr 2012; status: terminated.
02
Drugs
dovitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01484041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01484041.